What is the expected therapeutic result of using Methyl-prednisolone?

Methylprednisolone is a corticosteroid commonly used for its anti-inflammatory properties. The expected therapeutic result of using this medication is primarily the reduction in inflammation. Corticosteroids like methylprednisolone exert their effects by inhibiting the immune response, thereby decreasing the production of inflammatory mediators such as cytokines. This action can be beneficial in a variety of conditions characterized by excessive inflammation, including allergies, autoimmune disorders, and certain pulmonary conditions.

While increased oxygen delivery, increased blood glucose, and improved electrolyte balance may be observed as secondary effects in certain clinical scenarios, they are not the primary therapeutic aims when prescribing methylprednisolone. Increased blood glucose can occur as a side effect because corticosteroids can influence glucose metabolism; however, this is not the goal of therapy. Improving electrolyte balance is also not a primary effect of methylprednisolone. Therefore, the focus on reducing inflammation is what makes it the correct answer in this context.